153 related articles for article (PubMed ID: 37086173)
1. Maintenence rituximab following induction in autoimmune cytopenias.
Rai MP; Lee EJ; Bussel JB
Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
5. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
Li H; Ji J; Du Y; Huang Y; Gu H; Chen M; Wu R; Han B
Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
[TBL] [Abstract][Full Text] [Related]
7. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
[TBL] [Abstract][Full Text] [Related]
8. Expanded utilization of rituximab in paediatric cardiac transplant patients.
Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience.
Jasinski S; Weinblatt ME; Glasser CL
J Pediatr Hematol Oncol; 2017 Aug; 39(6):420-424. PubMed ID: 28267088
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
[TBL] [Abstract][Full Text] [Related]
11. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
[TBL] [Abstract][Full Text] [Related]
13. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome.
Rodella E; Pacquola E; Bianchini E; Ramazzina E; Paolini R
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554
[TBL] [Abstract][Full Text] [Related]
14. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
15. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
16. Infection risk in autoimmune hematological disorders with low-dose rituximab treatment.
Wang H; Yan S; Liu H; Li L; Song J; Wang G; Wang H; Wu Y; Shao Z; Fu R
J Clin Lab Anal; 2020 Oct; 34(10):e23455. PubMed ID: 32794271
[TBL] [Abstract][Full Text] [Related]
17. Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome.
Galor A; O'Brien T
Int J Hematol; 2003 Nov; 78(4):335-6. PubMed ID: 14686491
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.
Miano M; Ramenghi U; Russo G; Rubert L; Barone A; Tucci F; Farruggia P; Petrone A; Mondino A; Lo Valvo L; Crescenzio N; Bellia F; Olivieri I; Palmisani E; Caviglia I; Dufour C; Fioredda F
Br J Haematol; 2016 Nov; 175(3):490-495. PubMed ID: 27447678
[TBL] [Abstract][Full Text] [Related]
19. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
Ottaviano G; Marinoni M; Graziani S; Sibson K; Barzaghi F; Bertolini P; Chini L; Corti P; Cancrini C; D'Alba I; Gabelli M; Gallo V; Giancotta C; Giordano P; Lassandro G; Martire B; Angarano R; Mastrodicasa E; Bava C; Miano M; Naviglio S; Verzegnassi F; Saracco P; Trizzino A; Biondi A; Pignata C; Moschese V
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):273-282. PubMed ID: 31377437
[TBL] [Abstract][Full Text] [Related]
20. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
